Jinhe Biotechnology (002688.SZ): Lumpy Skin Disease Inactivated Vaccine (NMG Strain) Obtained New Veterinary Drug Registration Certificate

Zhitong Finance APP news, Jinhe Biotechnology (002688.SZ) issued an announcement. According to the provisions of the "Veterinary Drug Management Regulations" and the "Veterinary Drug Registration Measures," after review by the Ministry of Agriculture and Rural Affairs, the bovine lumpy skin disease inactivated vaccine (NMG strain) jointly developed by the company's subsidiary Jinhe Youben Biological Products Co., Ltd. (hereinafter referred to as "Jinhe Youben"), Jinyu Baoling Biological Pharmaceutical Co., Ltd., and Luoyang Wopson Bioengineering Co., Ltd. was approved as a new veterinary drug, and the "New Veterinary Drug Registration Certificate" was issued.